News | June 03, 2014

Cancer treatment equipment and oncology information system to increase efficiency and standard of treatment


June 3, 2014 — Elekta announced it signed an agreement to provide the Centre Hospitalier de l'Universite de Montreal (University of Montreal Health Centre, or CHUM) with advanced linear accelerators and software. The order, resulting from a competitive tender process, is valued at more than $20 million USD and was booked during Elekta's fourth quarter of its fiscal year 2013/14.

The CHUM was formed through the merger of three teaching hospitals, including the 372-year old Hotel-Dieu Hospital. It is one of the largest hospitals in Canada and a leading academic center in the province of Quebec. To increase the efficiency of its new integrated cancer center, the CHUM has chosen the Mosaiq oncology information system (OIS) to manage the complete spectrum of oncology treatments in a single patient record accessible by its 17 multidisciplinary teams across multiple locations.

The partnership agreement also includes Infinity linear accelerators (linacs) with Agility multileaf collimators (MLCs). At the core of a new radiotherapy treatment platform, this technology will offer CHUM's clinicians superior dose conformance and treatment speed as well as high-resolution beam shaping. For patients, it means safer, faster treatment with less risk of damage to healthy tissue.

David Roberge, M.D., head of radiation oncology at CHUM, said, "We chose Elekta, not simply for the advanced capabilities of its linear accelerators, but because of our shared vision for improving cancer management. Together, we will better integrate our cancer care activities — whether it be clinical research, screening, surgery, systemic therapy, radiation, survivorship or palliative care. Mosaiq will ensure that patients have the most efficient management options available."

For more information: www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now